20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with arachidonyl dopamine in 1 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (arachidonyl dopamine) | Trials (arachidonyl dopamine) | Recent Studies (post-2010) (arachidonyl dopamine) |
---|---|---|---|---|---|
640 | 13 | 233 | 62 | 0 | 22 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basnet, A; Bradshaw, HB; Rimmerman, N; Tan, B; Walker, JM; Widlanski, TS | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and arachidonyl dopamine
Article | Year |
---|---|
Microsomal omega-hydroxylated metabolites of N-arachidonoyl dopamine are active at recombinant human TRPV1 receptors.
Topics: Animals; Arachidonic Acids; Cytochrome P-450 Enzyme System; Dopamine; Humans; Hydroxyeicosatetraenoic Acids; Kinetics; Mass Spectrometry; Microsomes, Liver; Rats; Recombinant Proteins; TRPV Cation Channels | 2009 |